The Europe Stem Cell Assay Market was worth USD 140.7 Million in 2016 and is estimated to be growing at a CAGR of 19.3%, to reach USD 340.11 Million by 2021. Stem cells are a type of cells in human body and possess the ability to develop into any other cell in the body. After cell division, they can again produce stem cells. Due to this regenerative ability of the stem cells, they are capable of repairing damaged tissues or organs.

There are two major sources of stem cells in humans. One is from the blastocyst stage of human embryo and the other is adult stem cells and are available from bone marrow, brain, spinal cord etc. Stem cells are applied in medicine to develop therapies for diseases such as Alzheimer’s. Stem cell assays analyze the functional capabilities of derived stem cells and assess the quality of the cells.

View full report @ http://www.marketdataforecast.com/market-reports/europe-stem-cell-assay-market-3675/

Rise in aging population and chronic diseases, increase in investments for research on stem cells and the development of stem cell therapy are the major factors driving the stem cell assays market. Increases restrictions on the use of animals to test the drugs, demand for stem cell assays increased. However, huge costs associated with the research on stem cells and controversies arising because the source of stem cells being the human embryo is restraining the market.

The Europe stem cell assay market is segmented based on assay type, technology, kits, product, application, end user and region. Based on the assay type, the market is categorized into Cell Viability & Toxicity Assays, Purification Assays, Differentiation assays, function assays, Identification assays, proliferation assays and cell apoptosis assays. The cell viability and toxicity assay is projected to hold the largest market share due to increase in focus on drug testing using stem cells. Based on kits, the market is categorized into Adult stem cell kits and human embryonic stem cell kits. Adult stem cells kits are again segmented into Induced Pluripotent Stem Cell Kits, Mesenchymal Stem Cell Kits, Hematopoietic Stem Cell Kits, Umbilical Cord Stem Cells and Neuronal Stem Cells Kits. Due to the high effectiveness in the analysis of stem cells, adult stem cell kits segment is rapidly growing. Based on product, the market is categorized into Instruments and Detection kits. Instruments are further categorized into Flow cytometer, Cell imaging systems, Micro electrode arrays and automated cell counter. Detection kits include immune histochemistry kits. Flow cytometer is the fastest growing segment due to the rise in demand for tissue analysis and application of cytometers in cancer detection. Based on application, the market is categorized into Regenerative Medicine & Therapy Development, Drug Discovery and Development and clinical research. Regenerative medicine segment is again categorized into Dermatology, Cardiovascular, Orthopedic & Musculoskeletal Spine, Oncology, Central Nervous System and diabetes. Due to the increase in prevalence of chronic diseases, the demand for regenerative medicine has increased attributing to its largest market share. Based on the end users, the market is categorized into research institutes and industry research.

Request sample @ http://www.marketdataforecast.com/market-reports/europe-stem-cell-assay-market-3675/request-sample

Based on region, the Europe stem cell assays market is segmented into UK, Germany, Spain, France and Italy. Germany leads the market in this region due to the increasing adoption of stem cell based research in this country.

Major companies in the stem cell assay market are Merck KGaA, Bio-Techne Corporation, Promega Corporation, Thermo Fisher Scientific Inc., STEMCELL Technologies Inc., Hemogenix, GE Healthcare, Bio-Rad Laboratories, Inc., Cellular Dynamics International Inc., and Cell Biolabs Inc.